Compugen (CGEN) Research & Development (2009 - 2026)
Compugen recorded quarterly Research & Development of $6.9 million in Q1 2026, up 20.16% quarter-over-quarter from $5.8 million in Q1 2025, and up 20.16% year-over-year from $5.8 million in Q1 2025.
Compugen's Research & Development history runs 3 years deep, the most recent figure standing at $6.9 million for Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 6.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.94 Mn |
| Dec 31, 2025 | 5.54 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Jun 30, 2025 | 5.64 Mn |
| Mar 31, 2025 | 5.77 Mn |
| Dec 31, 2024 | 5.91 Mn |
| Sep 30, 2024 | 6.31 Mn |
| Jun 30, 2024 | 6.18 Mn |
| Mar 31, 2024 | 6.41 Mn |
| Dec 31, 2023 | 10.93 Mn |
| Sep 30, 2023 | 8.34 Mn |
| Jun 30, 2023 | 7.76 Mn |
| Mar 31, 2023 | 7.45 Mn |
| Dec 31, 2022 | 7.33 Mn |
| Sep 30, 2022 | 9.34 Mn |
| Jun 30, 2022 | 6.81 Mn |
| Mar 31, 2022 | 7.17 Mn |
| Dec 31, 2021 | 5.84 Mn |
| Sep 30, 2021 | 8.73 Mn |
| Jun 30, 2021 | 6.80 Mn |
| Mar 31, 2021 | 7.33 Mn |
| Dec 31, 2020 | 8.10 Mn |
| Sep 30, 2020 | 5.50 Mn |
| Jun 30, 2020 | 4.45 Mn |
| Mar 31, 2020 | 4.71 Mn |
| Dec 31, 2019 | 4.31 Mn |
| Sep 30, 2019 | 4.30 Mn |
| Jun 30, 2019 | 4.87 Mn |
| Mar 31, 2019 | 6.34 Mn |
| Dec 31, 2018 | 7.46 Mn |
| Sep 30, 2018 | 7.76 Mn |
| Jun 30, 2018 | 8.03 Mn |
| Mar 31, 2018 | 7.07 Mn |
| Dec 31, 2017 | 7.17 Mn |
| Sep 30, 2017 | 7.62 Mn |
| Jun 30, 2017 | 7.06 Mn |
| Mar 31, 2017 | 6.73 Mn |
| Dec 31, 2016 | 6.31 Mn |
| Sep 30, 2016 | 6.00 Mn |
| Jun 30, 2016 | 5.46 Mn |
| Mar 31, 2016 | 6.77 Mn |
| Dec 31, 2015 | 5.80 Mn |
| Sep 30, 2015 | 5.33 Mn |
| Jun 30, 2015 | 5.19 Mn |
| Mar 31, 2015 | 4.79 Mn |
| Dec 31, 2014 | 4.85 Mn |
| Sep 30, 2014 | 3.91 Mn |
| Jun 30, 2014 | 3.07 Mn |
| Mar 31, 2014 | 3.24 Mn |
| Dec 31, 2013 | 3.26 Mn |
| Sep 30, 2013 | 2.84 Mn |
| Jun 30, 2013 | 3.44 Mn |
| Mar 31, 2013 | 2.74 Mn |
| Dec 31, 2012 | 2.61 Mn |
| Sep 30, 2012 | 2.79 Mn |
| Jun 30, 2012 | 1.95 Mn |
| Mar 31, 2012 | 2.10 Mn |
| Dec 31, 2011 | 1.85 Mn |
| Sep 30, 2011 | 2.11 Mn |
| Jun 30, 2011 | 1.17 Mn |
| Mar 31, 2011 | 1.69 Mn |
| Dec 31, 2010 | 1.55 Mn |
| Sep 30, 2010 | 1.23 Mn |
| Jun 30, 2010 | 1.34 Mn |
| Mar 31, 2010 | 1.64 Mn |
| Dec 31, 2009 | 1.63 Mn |
| Sep 30, 2009 | 1.45 Mn |
| Jun 30, 2009 | 1.51 Mn |
| Mar 31, 2009 | 1.41 Mn |